Cat Donaldson

Cat Donaldson is a seasoned professional with extensive experience in biotechnology and healthcare management. Currently serving as Head of Operations at NILO Therapeutics since May 2024, Cat also contributes as a member of the Advisory Council at the UK Research Integrity Office since April 2021. Previously, Cat held critical leadership roles at Alexandria Real Estate Equities, Inc., overseeing LaunchLabs and serving as Executive Director of LaunchLabs NYC from June 2021 to April 2024. Cat's career further includes a significant tenure at Cold Spring Harbor Laboratory, where responsibilities spanned from Chief Development Officer to various managerial roles in biotechnology and business development. Cat began the professional journey as a Postdoctoral Researcher at Stony Brook Medicine from May 2013 to August 2015. Academically, Cat holds a Doctor of Philosophy in Biochemistry from the University of Cambridge and an MBA in Health Care Administration from Stony Brook University, among other degrees from the University of Cambridge.